Sort by

Send to

Choose Destination

Search results

Items: 4


Efficacy and safety of a double-coated paclitaxel-eluting coronary stent: the EUCATAX trial.

Rodriguez AE, Vigo CF, Delacasa A, Mieres J, Fernandez-Pereira C, Bernardi V, Bettinoti M, Rodriguez-Granillo AM, Rodriguez-Granillo G, Santaera O, Curotto V, Rubilar B, Tronge J, Palacios IF, Antoniucci D; EUCATAX Investigators.

Catheter Cardiovasc Interv. 2011 Feb 15;77(3):335-42. doi: 10.1002/ccd.22769. Epub 2010 Nov 30.


Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) study.

Rodriguez AE, Maree A, Tarragona S, Fernandez-Pereira C, Santaera O, Rodriguez Granillo AM, Rodriguez-Granillo GA, Russo-Felssen M, Kukreja N, Antoniucci D, Palacios IF, Serruys PW; ORAR III Investigators.

EuroIntervention. 2009 Jun;5(2):255-64.


Early assessment of myocardial viability by the use of delayed enhancement computed tomography after primary percutaneous coronary intervention.

Rodriguez-Granillo GA, Rosales MA, Baum S, Rennes P, Rodriguez-Pagani C, Curotto V, Fernandez-Pereira C, Llaurado C, Risau G, Degrossi E, Doval HC, Rodriguez AE.

JACC Cardiovasc Imaging. 2009 Sep;2(9):1072-81. doi: 10.1016/j.jcmg.2009.03.023.


Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry.

Rodriguez AE, Maree AO, Mieres J, Berrocal D, Grinfeld L, Fernandez-Pereira C, Curotto V, Rodriguez-Granillo A, O'Neill W, Palacios IF.

Eur Heart J. 2007 Sep;28(17):2118-25. Epub 2007 Jul 25.


Supplemental Content

Loading ...
Support Center